No Data
No Data
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Keen Vision Acquisition Corp. Merger
Keen Vision Acquisition, Medera to Merge
Cardiovascular pharmaceutical company Medera plans to go public in the United States through a reverse merger, with a valuation exceeding $0.6 billion.
Medera Inc. has reached an agreement with special purpose acquisition company Keen Vision Acquisition Corp. to go public on Nasdaq through a merger.
Madera Says Merger Values It at a Pre-Money Valuation of $622.6M >KVAC
Express News | Keen Vision Acquisition Corp - Combined Company to Have Enterprise Value of $622.6 Million
Express News | Medera Inc. to Be Listed on Nasdaq Through a Merger Agreement With Keen Vision Acquisition Corporation
No Data
No Data